NO20070837L - Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. - Google Patents
Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.Info
- Publication number
- NO20070837L NO20070837L NO20070837A NO20070837A NO20070837L NO 20070837 L NO20070837 L NO 20070837L NO 20070837 A NO20070837 A NO 20070837A NO 20070837 A NO20070837 A NO 20070837A NO 20070837 L NO20070837 L NO 20070837L
- Authority
- NO
- Norway
- Prior art keywords
- pyrido
- preparation
- pyrimidine derivatives
- cancer
- treatment
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- YYBMDGRYICXNMH-UHFFFAOYSA-N pyrimido[5,4-b][1,5]naphthyridine Chemical class N1=CN=CC2=C1C=C1C(=N2)C=CC=N1 YYBMDGRYICXNMH-UHFFFAOYSA-N 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 159000000018 pyrido[2,3-d]pyrimidines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen angår pyrido[2,3-d]pyrimidinderivater med den generelle formel (I), i form av en base, et addisjonssalt eller en farmasøytisk akseptabel syre, i form av hydrater eller solvater, men også i form av enantiomerer, diastereomerer og blandinger derav, samt deres fremstilling. Oppfinnelsen omhandler også en fremgangsmåte for fremstilling av nevnte derivater, farmasøytiske sammensetninger inneholdende en forbindelse med den generelle formel (I), og deres terapeutiske anvendelse.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0407898A FR2873118B1 (fr) | 2004-07-15 | 2004-07-15 | Derives de pyrido-pyrimidine, leur application en therapeutique |
| PCT/FR2005/001809 WO2006016067A2 (fr) | 2004-07-15 | 2005-07-13 | Derives de pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20070837L true NO20070837L (no) | 2007-04-16 |
Family
ID=34947008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20070837A NO20070837L (no) | 2004-07-15 | 2007-02-13 | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US7544682B2 (no) |
| EP (1) | EP1773835B1 (no) |
| JP (1) | JP5161568B2 (no) |
| KR (1) | KR101236676B1 (no) |
| CN (1) | CN101124223A (no) |
| AR (1) | AR049845A1 (no) |
| AU (1) | AU2005271071B2 (no) |
| BR (1) | BRPI0513287A (no) |
| CA (1) | CA2572614A1 (no) |
| CR (1) | CR8842A (no) |
| EA (1) | EA011406B1 (no) |
| EC (1) | ECSP067111A (no) |
| FR (1) | FR2873118B1 (no) |
| GT (1) | GT200500191A (no) |
| HN (1) | HN2005000370A (no) |
| IL (1) | IL180256A (no) |
| MA (1) | MA28742B1 (no) |
| MX (1) | MX2007000508A (no) |
| NO (1) | NO20070837L (no) |
| PA (1) | PA8639301A1 (no) |
| PE (1) | PE20060380A1 (no) |
| SV (1) | SV2006002170A (no) |
| TN (1) | TNSN06440A1 (no) |
| TW (1) | TWI391390B (no) |
| UA (1) | UA95223C2 (no) |
| UY (1) | UY29015A1 (no) |
| WO (1) | WO2006016067A2 (no) |
| ZA (1) | ZA200700992B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2873118B1 (fr) * | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | Derives de pyrido-pyrimidine, leur application en therapeutique |
| BRPI0610133A2 (pt) * | 2005-05-17 | 2010-06-01 | Schering Corp | heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia |
| US7737155B2 (en) * | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| US7750015B2 (en) * | 2005-05-17 | 2010-07-06 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| FR2887882B1 (fr) | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
| FR2896246B1 (fr) | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
| CN101400682A (zh) * | 2006-01-20 | 2009-04-01 | 先灵公司 | 治疗异常脂血症的杂环烟酸受体激动剂 |
| FR2910813B1 (fr) | 2006-12-28 | 2009-02-06 | Sanofi Aventis Sa | Nouvelle utilisation therapeutique pour le traitement des leucemies |
| TW200835497A (en) * | 2007-01-11 | 2008-09-01 | Astrazeneca Ab | Chemical compounds 636 |
| SA08280783B1 (ar) * | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| ES2608940T3 (es) * | 2007-06-15 | 2017-04-17 | Msd K.K. | Derivado de bicicloanilina |
| FR2933701A1 (fr) * | 2008-07-08 | 2010-01-15 | Sanofi Aventis | Derives anticancereux, leur preparation et leur application en therapeutique |
| FR2955109B1 (fr) * | 2010-01-08 | 2012-09-07 | Sanofi Aventis | Derives de 5-oxo-5,8-dihydro-pyrido[2, 3-d]pyrimidine, leur preparation et leur application en therapeutique |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1171218A (en) | 1967-11-09 | 1969-11-19 | Parke Davis & Co | New Heterocyclic Amine Compounds and Methods for their Production |
| HUT76853A (en) * | 1994-11-14 | 1997-12-29 | Warner Lambert Co | 6-aryl pyrido[2,3-d]pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation and pharmaceutical compositions containing the same |
| IL115256A0 (en) * | 1994-11-14 | 1995-12-31 | Warner Lambert Co | 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use |
| IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
| US5620981A (en) * | 1995-05-03 | 1997-04-15 | Warner-Lambert Company | Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| EP1218336A2 (en) | 1999-09-20 | 2002-07-03 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
| US7053070B2 (en) * | 2000-01-25 | 2006-05-30 | Warner-Lambert Company | Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors |
| CZ20022475A3 (cs) | 2000-01-25 | 2003-03-12 | Warner-Lambert Company | Pyrido[2,3-d]pyrimidin-2,7-diaminové inhibitory kinázy |
| PL358271A1 (pl) | 2000-03-06 | 2004-08-09 | Warner-Lambert Company | 5-alkilopirydo[2,3-D]pirymidyny jako inhibitory kinazy tyrozyny |
| CA2417942C (en) | 2000-08-04 | 2010-06-29 | Warner-Lambert Company | 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| WO2003000011A2 (en) | 2001-06-21 | 2003-01-03 | Ariad Pharmaceuticals, Inc. | Novel pyridopyrimidines and uses thereof |
| WO2003026664A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Corporation | 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| AU2002361846A1 (en) * | 2001-12-21 | 2003-07-15 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| EP1492790A1 (en) * | 2002-04-03 | 2005-01-05 | F. Hoffmann-La Roche Ag | Imidazo fused compounds |
| AU2002952453A0 (en) * | 2002-11-01 | 2002-11-21 | Novogen Research Pty Ltd | Aminated isoflavonoid derivatives and uses thereof |
| TW200413381A (en) * | 2002-11-04 | 2004-08-01 | Hoffmann La Roche | Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| WO2004063195A1 (en) | 2003-01-03 | 2004-07-29 | Sloan-Kettering Institute For Cancer Research | Pyridopyrimidine kinase inhibitors |
| TW200502236A (en) * | 2003-03-28 | 2005-01-16 | Hoffmann La Roche | Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| AU2004279427B2 (en) * | 2003-10-08 | 2008-07-03 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| WO2005105097A2 (en) | 2004-04-28 | 2005-11-10 | Gpc Biotech Ag | Pyridopyrimidines for treating inflammatory and other diseases |
| FR2873118B1 (fr) * | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | Derives de pyrido-pyrimidine, leur application en therapeutique |
| FR2887882B1 (fr) | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
| FR2896246B1 (fr) | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
-
2004
- 2004-07-15 FR FR0407898A patent/FR2873118B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-13 EA EA200700144A patent/EA011406B1/ru not_active IP Right Cessation
- 2005-07-13 WO PCT/FR2005/001809 patent/WO2006016067A2/fr not_active Ceased
- 2005-07-13 KR KR1020077000780A patent/KR101236676B1/ko not_active Expired - Fee Related
- 2005-07-13 JP JP2007520863A patent/JP5161568B2/ja not_active Expired - Fee Related
- 2005-07-13 UA UAA200701578A patent/UA95223C2/ru unknown
- 2005-07-13 EP EP05788772.1A patent/EP1773835B1/fr not_active Expired - Lifetime
- 2005-07-13 MX MX2007000508A patent/MX2007000508A/es active IP Right Grant
- 2005-07-13 CN CNA2005800278656A patent/CN101124223A/zh active Pending
- 2005-07-13 CA CA002572614A patent/CA2572614A1/fr not_active Abandoned
- 2005-07-13 AR ARP050102895A patent/AR049845A1/es unknown
- 2005-07-13 ZA ZA200700992A patent/ZA200700992B/en unknown
- 2005-07-13 AU AU2005271071A patent/AU2005271071B2/en not_active Ceased
- 2005-07-13 SV SV2005002170A patent/SV2006002170A/es unknown
- 2005-07-13 BR BRPI0513287-8A patent/BRPI0513287A/pt not_active IP Right Cessation
- 2005-07-14 HN HN2005000370A patent/HN2005000370A/es unknown
- 2005-07-14 TW TW094123921A patent/TWI391390B/zh not_active IP Right Cessation
- 2005-07-14 UY UY29015A patent/UY29015A1/es not_active Application Discontinuation
- 2005-07-14 PA PA20058639301A patent/PA8639301A1/es unknown
- 2005-07-14 PE PE2005000811A patent/PE20060380A1/es not_active Application Discontinuation
- 2005-07-14 GT GT200500191A patent/GT200500191A/es unknown
-
2006
- 2006-12-21 IL IL180256A patent/IL180256A/en not_active IP Right Cessation
- 2006-12-26 EC EC2006007111A patent/ECSP067111A/es unknown
- 2006-12-26 TN TNP2006000440A patent/TNSN06440A1/fr unknown
-
2007
- 2007-01-08 US US11/651,376 patent/US7544682B2/en not_active Expired - Fee Related
- 2007-01-09 CR CR8842A patent/CR8842A/es unknown
- 2007-01-17 MA MA29620A patent/MA28742B1/fr unknown
- 2007-02-13 NO NO20070837A patent/NO20070837L/no not_active Application Discontinuation
-
2009
- 2009-03-31 US US12/415,256 patent/US7893259B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| NO20075169L (no) | Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme. | |
| TW200621762A (en) | Novel compounds | |
| ATE450533T1 (de) | Carboxamidderivate | |
| MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| IL187438A0 (en) | Pyrrolopyridine derivatives and pharmaceutical compositions containing the same | |
| DE602004007239D1 (de) | 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN | |
| ATE437872T1 (de) | Proteinkinaseinhibitoren | |
| MXPA05012466A (es) | Derivados de quinolina como inhibidores de fosfodiesterasa. | |
| NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| TW200613243A (en) | Novel compounds | |
| TW200508207A (en) | New benzimidazole derivatives | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| MY140630A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| TW200626553A (en) | Novel compounds | |
| TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| MXPA05013050A (es) | Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos. | |
| SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| TW200606164A (en) | New compounds | |
| WO2007080324A3 (fr) | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. | |
| SE0301371D0 (sv) | New Compounds | |
| IL181666A0 (en) | Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof | |
| NO20055997L (no) | Diarylmetylidenpiperidinderivater og deres anvendelse som opiodreseptoragonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |